Eysys Pharmaceuticals

Chennai, India
Pharmaceutical solutions and healthcare products focused on quality medical management in India.
Annual revenue $10.9M Latest available
Total funding - Funding intelligence
Employees 58 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Eysys Pharmaceuticals

Eysys Pharmaceuticals is a company based in Chennai (India). The company has 58 employees as of April 06, 2024. Eysys Pharmaceuticals offers products and services including ATHENA and OSTARA.

  • Headquarter Chennai, India
  • Employees 58 as on 06 Apr, 2024
  • Sectors
    Healthcare
  • Phone
    Locked
  • Legal Name Eysys Pharmaceutical Pvt Ltd
  • Jurisdiction Chennai, Tamil Nadu, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $10.91 M (USD)
    5.8
    as on Mar 31, 2023
  • Net Profit
    $375.38 K (USD)
    -32.48
    as on Mar 31, 2023
  • EBITDA
    $5.53 K (USD)
    -99.19
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    58

    as on Apr 06, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Eysys Pharmaceuticals

Eysys Pharmaceuticals offers a comprehensive portfolio of products and services, including ATHENA and OSTARA.

Product name locked
Category locked
Primary

A pharmaceutical product is provided for cardia and diabetic management within the company's portfolio.

Product name locked
Category locked
Locked

Products are offered for gastro, respiratory, and pain management as part of the company's healthcare solutions.

Funding Insights of Eysys Pharmaceuticals

Premium access

Detailed funding history for Eysys Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Eysys Pharmaceuticals

Investments
Premium access

Investment portfolio details for Eysys Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Eysys Pharmaceuticals

Premium access

Detailed financials for Eysys Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Eysys Pharmaceuticals Comparisons

Eysys Pharmaceuticals Primary company
Description
Pharmaceutical solutions and healthcare products focused on ...
Location
Chennai, India
Founded Year
-
Annual Revenue
$10.91 M (USD)
Net Profit
$375.38 K (USD)
EBITDA
$5.53 K (USD)
Employees
58
As of 2024
Premium access

Peer comparison for Eysys Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Eysys Pharmaceuticals

Premium access

Detailed competitors of Eysys Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Eysys Pharmaceuticals

Premium access

Complete news archive for Eysys Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Eysys Pharmaceuticals

Eysys Pharmaceuticals is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

As of Apr 06, 2024, the latest employee count at Eysys Pharmaceuticals is 58.

Annual revenue of Eysys Pharmaceuticals is $10.91M as on Mar 31, 2023.

Eysys Pharmaceuticals is recognized for its diverse portfolio of over 100 healthcare solutions, which are developed with a focus on quality and affordability. The company was established in Kerala in 2014 as ISIS Healthcare and is now headquartered in Chennai. It is supported by an extensive network of over 400 channel partners and 1,000 medical experts, ensuring reliable delivery of pharmaceutical products across various therapeutic areas. Efforts are directed towards maintaining ethical standards and expanding access to critical medicines nationwide, with a commitment to serving users through innovative approaches.

Eysys Pharmaceuticals offers ATHENA and OSTARA.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available